'I know those people will be approachable and not mistreat us': a qualitative study of inspectors and private drug sellers' views on peer supervision in rural Uganda.


Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
27 10 2020
Historique:
received: 15 05 2020
accepted: 15 10 2020
entrez: 28 10 2020
pubmed: 29 10 2020
medline: 10 4 2021
Statut: epublish

Résumé

Peer supervision improves health care delivery by health workers. However, in rural Uganda, self-supervision is what is prescribed for licensed private drug sellers by statutory guidelines. Evidence shows that self-supervision encourages inappropriate treatment of children less than 5 years of age by private drug sellers. This study constructed a model for an appropriate peer supervisor to augment the self-supervision currently practiced by drug sellers at district level in rural Uganda. In this qualitative study, six Key informant interviews were held with inspectors while ten focus group discussions were conducted with 130 drug sellers. Data analysis was informed by the Kathy Charmaz constructive approach to grounded theory. Atlas ti.7 software package was used for data management. A model with four dimensions defining an appropriate peer supervisor was developed. The dimensions included; incentives, clearly defined roles, mediation and role model peer supervisor. While all dimensions were regarded as being important, all participants interviewed agreed that incentives for peer supervisors were the most crucial. Overall, an appropriate peer supervisor was described as being exemplary to other drug sellers, operated within a defined framework, well facilitated to do their role and a good go-between drug sellers and government inspectors. Four central contributions advance literature by the model developed by our study. First, the model fills a supervision gap for rural private drug sellers. Second, it highlights the need for terms of reference for peer supervisors. Third, it describes who an appropriate peer supervisor should be. Lastly, it elucidates the kind of resources needed for peer supervision.

Sections du résumé

BACKGROUND
Peer supervision improves health care delivery by health workers. However, in rural Uganda, self-supervision is what is prescribed for licensed private drug sellers by statutory guidelines. Evidence shows that self-supervision encourages inappropriate treatment of children less than 5 years of age by private drug sellers. This study constructed a model for an appropriate peer supervisor to augment the self-supervision currently practiced by drug sellers at district level in rural Uganda.
METHODS
In this qualitative study, six Key informant interviews were held with inspectors while ten focus group discussions were conducted with 130 drug sellers. Data analysis was informed by the Kathy Charmaz constructive approach to grounded theory. Atlas ti.7 software package was used for data management.
RESULTS
A model with four dimensions defining an appropriate peer supervisor was developed. The dimensions included; incentives, clearly defined roles, mediation and role model peer supervisor. While all dimensions were regarded as being important, all participants interviewed agreed that incentives for peer supervisors were the most crucial. Overall, an appropriate peer supervisor was described as being exemplary to other drug sellers, operated within a defined framework, well facilitated to do their role and a good go-between drug sellers and government inspectors.
CONCLUSION
Four central contributions advance literature by the model developed by our study. First, the model fills a supervision gap for rural private drug sellers. Second, it highlights the need for terms of reference for peer supervisors. Third, it describes who an appropriate peer supervisor should be. Lastly, it elucidates the kind of resources needed for peer supervision.

Identifiants

pubmed: 33109214
doi: 10.1186/s12992-020-00636-6
pii: 10.1186/s12992-020-00636-6
pmc: PMC7590471
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106

Références

Hum Resour Health. 2017 Sep 2;15(1):58
pubmed: 28865466
PLoS One. 2017 May 16;12(5):e0177698
pubmed: 28520768
BMC Med Educ. 2015 Jun 11;15:103
pubmed: 26062608
Nurs Midwifery Stud. 2016 Feb 20;5(1):e31292
pubmed: 27331057
BMC Health Serv Res. 2017 Nov 28;17(1):786
pubmed: 29183314
Health Policy Plan. 2017 Apr 1;32(3):437-452
pubmed: 27993961
Implement Sci. 2019 Oct 25;14(1):93
pubmed: 31653254
Behav Res Ther. 2020 Jul;130:103533
pubmed: 31870496
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Int Breastfeed J. 2014 Nov 18;9:19
pubmed: 25784955
BMC Health Serv Res. 2012 Jul 27;12:223
pubmed: 22838649
Med Educ. 2000 Oct;34(10):827-40
pubmed: 11012933
Clin Med (Lond). 2014 Apr;14(2):149-56
pubmed: 24715126
East Afr Med J. 2004 Feb;Suppl:S33-40
pubmed: 15125114
J R Soc Med. 2007 Aug;100(8):375-8
pubmed: 17682031
Glob Health Action. 2014 May 08;7:24085
pubmed: 24815075
J Clin Nurs. 2017 Dec;26(23-24):4212-4222
pubmed: 28793362
BMC Public Health. 2014 Sep 22;14:987
pubmed: 25245825
Glob Health Action. 2016 Jun 24;9:31263
pubmed: 27345024
Front Psychol. 2019 Jul 09;10:1581
pubmed: 31338055
Health Policy Plan. 2007 Nov;22(6):393-403
pubmed: 17921151
Nurse Res. 2006 Jul 1;13(4):84
pubmed: 27702218
PLoS One. 2019 May 29;14(5):e0216444
pubmed: 31141509
Qual Health Res. 2012 Oct;22(10):1425-34
pubmed: 22865107
Cochrane Database Syst Rev. 2011 Nov 09;(11):CD008992
pubmed: 22071861
BMJ Glob Health. 2019 Oct 11;4(Suppl 9):e001151
pubmed: 31673434
Hum Resour Health. 2015 Sep 01;13:45
pubmed: 26324423
Cochrane Database Syst Rev. 2016 Aug 11;(8):CD009855
pubmed: 27510030
BMJ Open. 2016 Mar 15;6(3):e010632
pubmed: 26980439
PLoS One. 2014 Mar 21;9(3):e92323
pubmed: 24658124
Hum Resour Health. 2018 Feb 13;16(1):11
pubmed: 29439743

Auteurs

Arthur Bagonza (A)

Department of Community Health and Behavioural Sciences, Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda. abagonza@musph.ac.ug.

Stefan Peterson (S)

Department of Health Policy Planning and Management, Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda.
Department of Women's and Children's Health, International Maternal and Child Health Unit, Uppsala University, Uppsala, Sweden.

Andreas Mårtensson (A)

Department of Women's and Children's Health, International Maternal and Child Health Unit, Uppsala University, Uppsala, Sweden.

Milton Mutto (M)

Department of Disease Control and Environmental Health, Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda.

Phyllis Awor (P)

Department of Community Health and Behavioural Sciences, Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda.

Freddy Kitutu (F)

Department of Pharmacy, School of Health Sciences, Makerere University College of Health Sciences, Kampala, Uganda.

Linda Gibson (L)

School of Social Sciences, Nottingham Trent University, Nottingham, UK.

Henry Wamani (H)

Department of Community Health and Behavioural Sciences, Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH